Why the study?
Does idarucizumab safely and effectively reverse the anticoagulant effect of dabigatran in emergency situations?
Does idarucizumab safely and effectively reverse the anticoagulant effect of dabigatran in emergency situations?
Idarucizumab provides rapid, durable, and safe reversal of dabigatran anticoagulation in emergency situations.
May support emergency reversal decisions; leaves open need for randomized confirmation of outcomes.
In emergency situations, idarucizumab rapidly, durably, and safely reversed the anticoagulant effect of dabigatran. (Funded by Boehringer Ingelheim; RE-VERSE AD ClinicalTrials.gov number, NCT02104947 .).
No takes yet. Share an insight, caveat, or question.
Pollack et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: